ROCA ‘test’ sales suspended in the UK

Abcodia, the company that makes the ROCA screening ‘test’, has today announced that it has suspended sales of the tool in the UK.

Last month the ROCA test came under fire in America, with the FDA (Food and drug administration) issuing a statement alerting women to the risks associated with the use of such tools being marketed as ovarian cancer screening tests.

In a statement on its website , Abcodia said: “The ROCA Test is a risk estimation tool – not a standalone diagnostic test.”

Our Chief Executive, Katherine Taylor, said: “Despite extensive research – like the UKCTOCS study that many of you may have heard of or been involved in – there are currently no proven, reliable screening tests for ovarian cancer.

“The most important action you can take if you feel you are at risk or experiencing symptoms is to talk to your GP so they can investigate further if necessary.

“If you are worried about your family history it’s important to talk to your GP too. These tests are not proven to save lives so if you are at greater risk, from a BRCA1/2 gene mutation for example, it’s important to consider all of your available options.”

If you think you may be experiencing symptoms (persistent bloating, persistent tummy pain, needing to wee more often, feeling full very quickly) keep a symptoms diary to take along to your doctor. Search Ovarian Cancer Action in your phone’s app store or download a paper version here.